Recursion Pharmaceuticals, Inc. RXRX
3.52 USD +0.02 (+0.57%)
At closeNov 6, 2026, 7:59 PM EST
3.53 +0.01 +0.22%
After hours · Nov 6, 7:59 PM ET
3.48 Day range 3.65
2.84 52-week range 4.96
- YTD
- -13.94%
- 1 year
- -23.81%
Revenue & Expenses
Revenue by
Latest period ending Dec 31, 2025 · select a line to chart its full history
Annual income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 74.68M | 58.84M | 44.58M | 39.84M | 10.18M | |
| 74.68M | 58.84M | 44.58M | 39.84M | 10.18M | |
| 70.95M | 45.24M | 42.59M | 48.27M | 0 | |
| 3.73M | 13.60M | 1.99M | -8.43M | 10.18M | |
| 651.86M | 492.61M | 352.05M | 237.29M | 192.95M | |
| 475.27M | 314.42M | 241.23M | 155.70M | 135.27M | |
| 176.59M | 178.18M | 110.82M | 81.60M | 57.68M | |
| -648.13M | -479.00M | -350.06M | -245.73M | -182.78M | |
| -136.00K | -1.13M | -4.06M | 0 | 0 | |
| -644.76M | -463.66M | -328.07M | -239.48M | -186.48M | |
| -644.76M | -463.66M | -328.07M | -239.48M | -186.48M | |
| -644.76M | -463.66M | -328.07M | -239.48M | -186.48M | |
| -644.76M | -463.66M | -328.07M | -239.48M | -186.48M | |
| -1.44 | -1.69 | -1.58 | -1.36 | -1.49 | |
| -1.44 | -1.69 | -1.58 | -1.36 | -1.49 | |
| -1.44 | -1.69 | -1.58 | -1.36 | -1.49 | |
| -644.89M | -464.79M | -332.13M | -239.48M | -186.48M | |
| -644.89M | -464.79M | -332.13M | -239.48M | -186.48M | |
| 447.45M | 274.21M | 207.85M | 175.54M | 125.35M | |
| 447.45M | 274.21M | 207.85M | 175.54M | 125.35M |